ArticlePharmaceutical research2020

Preformulation Studies of a Stable PTEN-PDZ Lipopeptide Able to Cross an In Vitro Blood-Brain-Barrier Model as a Potential Therapy for Alzheimer's Disease.

Aikaterini Lalatsa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.